Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine and Mitoxantrone in Treating Participants With Previously Untreated Acute Myeloid Leukemia or High-Grade Myeloid Neoplasm

Conditions:   Acute Myeloid Leukemia;   High-Grade Myeloid Neoplasm Interventions:   Drug: Cladribine;   Drug: Cytarabine;   Drug: Gemtuzumab Ozogamicin;   Biological: Granulocyte Colony-Stimulating Factor;   Other: Laboratory Biomarker Analysis;   Drug: Mitoxantrone Hydrochloride Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials